TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott; Sahajanand Medical Technologies Ltd.
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Terumo Medical Corporation; Sahajanand Medical Technologies Ltd.; Elixir
- Equity/Stock(s)/Options - CERC